ChiCTR1900027311
正在进行
/
/
/
2019-11-08
/
/
Mild Cognitive Impairment
Photo Neuro-Modulation Therapy to Adults
Photo Neuro-Modulation Therapy to Middle Aged and Older Adults with Mild Memory Problem
It is well-documented that mild cognitive impairment (MCI) is associated frontal lobe dysfunction and executive dysfunction. In addition, many studies reported high level of MCI symptoms among the elderly and the trend is increasing in Hong Kong. Based upon the link between MCI and frontal and executive function problems, it is conceivable that elderly who exhibits high levels of cognitive impairments would exhibit frontal and executive function problems. To our knowledge, there is still a lack of effective treatment or therapy for MCI, it is important to investigate effective intervention that can efficiently improve the cognitive ability of MCI patients. The objective of the present study is to compare individuals with MCI after the Photoneuromodulation Therapy (PNMT) and those who do not. A hundred and twenty middle aged and older adults were recruited from the subject database of the Neuropsychology Laboratory of The Chinese University of Hong Kong. Participants were divided randomly and equally into experimental group, as well as the control group. Several computerized executive function tests will be used before and after the treatment under the recording of near-infrared spectroscopy (NIRS) or Electroencephalography (EEG), which estimates level of frontal activation. The changes in hemodynamic response and brain waves will be recorded as well. It is hypothesized that compared to participants without PNMT, those with PNMT will have a better performance in the executive function tasks and exhibit a higher frontal activation as measured by the neuropsychological assessment. The cognitive and neurophysiological results would provide evidences on the possibility of PNMT in treating individuals with MCI, as well as with other mental disorders. In addition, PNMT may induce an addition, PNMT may induce an increase in frontal oxyhemoglobin, measured by NIRS, and increases in alpha and beta wave in EEG recordings, based on previous findings.
随机抽样
Ⅰ期
Randomized computer calculation
N/A
n/a
/
40
/
2020-02-03
2020-07-31
/
40 middle age and older adults with aged 40 or above who have subjective memory complaints;
请登录查看A history of head injury, or any neurological/psychiatric disorders, and dementia will be excluded. In addition, a score higher than 7 on the short form of the Chinese Geriatric Depression Scale (CGDS-SF; Lee, Chiu, Kwok, & Leung, 1993);
请登录查看香港中文大學威爾斯親王醫院心理學系
/
香港中文大學威爾斯親王醫院心理學系的其他临床试验
香港中文大學威爾斯親王醫院心理學系的其他临床试验
最新临床资讯
-
Nat Rev Clin Oncol|AI赋能肿瘤临床试验:从流程优化到证据生成的全景透视
智药邦2026-08-12
-
康臣药业1类新药糖肾方“芪箭颗粒”获NMPA临床研究许可
康臣药业2026-08-12
-
璎黎药业2026-08-12
-
幂方健康基金2026-08-12
-
细胞与基因治疗领域2026-08-12
-
云南白药2026-08-12
-
细胞治疗前沿2026-08-12
-
广州达博生物制品有限公司2026-08-12
-
医药笔记2026-08-12
-
医药笔记2026-08-12
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 27
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 38
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
